
My Goat
Brings real-world examples to learning.
Always supportive and understanding.
Inspires curiosity and a love for knowledge.
A true inspiration to all learners.
Dr. Abidali Mohamedali is an Academic Casual and Adjunct Fellow in the School of Natural Sciences within the Faculty of Science and Engineering at Macquarie University. He completed his undergraduate studies in medical science, attaining a first-class Honours degree, at Macquarie University. He then pursued his PhD in molecular neuroscience under the supervision of Professors John Christodoulou and Patrick Tam at the Children's Medical Research Institute, completing it in 2011. Following his PhD, Dr. Mohamedali began his research career in cancer proteomics in Professor Mark S. Baker's laboratory, where he focused on early detection markers for colorectal cancer using novel ultradepletion technology involving chicken antibodies. During this period, he developed an interest in teaching and commenced his academic teaching career in biochemistry and cell biology. He subsequently completed a second postdoctoral position in glycomics and proteomics of colorectal cancer and a third in bioinformatics in Professor Shoba Ranganathan's laboratory, working extensively on missing proteins.
Currently, Dr. Mohamedali serves as a Lecturer in Leadership, Entrepreneurship, and Global Challenges in Science at Macquarie University. His research specializations include proteomics analysis for protein identification and quantification, cancer biomarker discovery particularly for early detection of colorectal and other cancers, bioinformatics methods such as recombinant protein spectral libraries for data-independent acquisition mass spectrometry, and protein biosignatures for predicting recurrence in stage II colorectal cancer. He has authored or co-authored over 40 research outputs, including peer-reviewed articles, reviews, book chapters, and encyclopedia entries. Notable publications are 'A proteomic examination of plasma extracellular vesicles across colorectal cancer stages uncovers biological insights that potentially improve prognosis' (2024, Cancers), 'Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management' (2024, BJC Reports), 'Recombinant Protein Spectral Library (rPSL) DIA-MS method improves identification and quantification of low-abundance cancer-associated and kynurenine pathway proteins' (2025, Communications Chemistry), 'Quantification of proteins from proteomic analysis' (2025, Encyclopedia of Bioinformatics and Computational Biology), and 'Identification of proteins from proteomic analysis' (2025, Encyclopedia of Bioinformatics and Computational Biology). Beyond academia, he is CEO of two businesses including a startup, President of Welfare Aid International, serves on boards of community organizations, and contributes to curriculum and teaching development.
